Epidermal growth factor enhances intestinal adaptation after massive small bowel resection

Area of Science:

• Gastroenterology
• Regenerative Medicine
• Surgical Research

Background:

• Epidermal growth factor (EGF) is known to promote tissue growth and repair.
• Massive small bowel (SB) resection leads to significant malabsorption and nutritional deficits.
• Intestinal adaptation is a critical process for recovery after SB loss.

Purpose of the Study:

• To investigate the efficacy of Epidermal Growth Factor (EGF) in promoting intestinal adaptation following extensive small bowel resection.
• To evaluate the impact of EGF on histological and biochemical parameters of the small bowel mucosa post-resection.

Main Methods:

• Sprague-Dawley rats underwent a 75% proximal small bowel resection or transection.
• Animals received continuous subcutaneous infusion of either saline or human recombinant EGF (6.25 µg/kg/h) for 28 days.
• Small bowel tissues were analyzed for weight, length, mucosal thickness, DNA, and protein content.

Main Results:

• EGF administration significantly increased animal weight, small bowel weight, length, and mucosal thickness compared to saline controls post-resection.
• Histological examination revealed enhanced mucosal hyperplasia in EGF-treated rats.
• Biochemical analyses indicated that EGF may augment the mucosal hyperplasia response.

Conclusions:

• Subcutaneous administration of EGF promotes significant intestinal adaptation after massive small bowel resection in rats.
• EGF enhances key parameters of intestinal healing and growth, suggesting a potential therapeutic role.
• EGF administration may offer nutritional benefits by improving the post-resection intestinal response.